Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lower Extremity Superficial Thrombophlebitis”

5 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 5 results

Post-approval studies (Phase 4)Study completedNCT05001776
What this trial is testing

Endovenous Laser Ablation in Acute Thrombophlebitis of the Varicose Great Saphenous Vein

Who this might be right for
Superficial Vein ThrombosisEndovenous Laser Ablation
National Medical Research Center for Therapy and Preventive Medicine 105
Post-approval studies (Phase 4)Study completedNCT00264381
What this trial is testing

Management of Superficial Thrombophlebitis

Who this might be right for
Superficial ThrombophlebitisUpper Extremity Superficial ThrombophlebitisLower Extremity Superficial Thrombophlebitis
University of Oklahoma 72
Not applicableStudy completedNCT00818688
What this trial is testing

POST (Prospective Observational Superfial Thrombophlebitis)

Who this might be right for
Thrombophlebitis
Centre Hospitalier Universitaire de Saint Etienne 844
Not applicableStudy completedNCT00954980
What this trial is testing

Evaluation of Endovenous Sclerotherapy for Treatment of Varicose Veins

Who this might be right for
Varicose Veins
University of Oklahoma 100
Large-scale testing (Phase 3)Study completedNCT00443053
What this trial is testing

Evaluation Of Fondaparinux (Also Called ARIXTRA) 2.5 mg Subcutaneously Once Daily For The Treatment Of Superficial Thrombophlebitis (Also Known As Superficial Vein Thrombosis)

Who this might be right for
Thrombosis, Venous
GlaxoSmithKline 3,002